Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab
Authors
Keywords
-
Journal
ANNALS OF NEUROLOGY
Volume 77, Issue 3, Pages 447-457
Publisher
Wiley
Online
2015-01-08
DOI
10.1002/ana.24345
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice
- (2015) M. Espiño et al. CLINICA CHIMICA ACTA
- Immunoglobulin M oligoclonal bands: Biomarker of targetable inflammation in primary progressive multiple sclerosis
- (2014) Luisa M. Villar et al. ANNALS OF NEUROLOGY
- Progressive multifocal leukoencephalopathy in patients with multiple sclerosis
- (2013) Kelly J. Baldwin et al. CURRENT OPINION IN NEUROLOGY
- Depleting tumor-specific Tregs at a single site eradicates disseminated tumors
- (2013) Aurélien Marabelle et al. JOURNAL OF CLINICAL INVESTIGATION
- Novel therapeutic options and drug targets in MS
- (2013) Axel Methner et al. Nature Reviews Neurology
- L-Selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients
- (2013) N. Schwab et al. NEUROLOGY
- Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation
- (2013) J. L. Jones et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunological Markers of Optimal Response to Natalizumab in Multiple Sclerosis
- (2012) Luisa M. Villar ARCHIVES OF NEUROLOGY
- TCR Bias and HLA Cross-Restriction Are Strategies of Human Brain-Infiltrating JC Virus-Specific CD4+ T Cells during Viral Infection
- (2012) S. Yousef et al. JOURNAL OF IMMUNOLOGY
- Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
- (2012) Gary Bloomgren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of CD4+ and CD8+ T-Cell Responses against JC Virus in the Outcome of Patients with Progressive Multifocal Leukoencephalopathy (PML) and PML with Immune Reconstitution Inflammatory Syndrome
- (2011) S. Gheuens et al. JOURNAL OF VIROLOGY
- Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring
- (2011) Ludwig Kappos et al. LANCET NEUROLOGY
- Induction of immune tolerance in the treatment of rheumatoid arthritis
- (2011) Salvatore Albani et al. Nature Reviews Rheumatology
- Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes
- (2011) Maria José Magraner et al. NEURORADIOLOGY
- Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis
- (2010) Erika Irie et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- The risk of relapse after a clinically isolated syndrome is related to the pattern of oligoclonal bands
- (2010) I. Boscá et al. JOURNAL OF NEUROIMMUNOLOGY
- Response to interferon in multiple sclerosis is related to lipid-specific oligoclonal IgM bands
- (2010) I. Bosca et al. Multiple Sclerosis Journal
- Effective use of JC virus PCR for diagnosis of progressive multifocal leukoencephalopathy
- (2009) Y. Wang et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis
- (2008) M Thangarajh et al. Multiple Sclerosis Journal
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started